1 Report Prologue
2 Market Introduction
2.1 Definition 20
2.2 Scope Of The Study 20
2.3 List Of Assumptions 20
2.4 Market Structure 21
3 Research Methodology
3.1 Research Process 23
3.2 Primary Research 24
3.3 Secondary Research 25
3.4 Market Size Estimation 26
3.5 Forecast Model 26
4 Market Dynamics
4.1 Overview 28
4.2 Drivers 29
4.2.1 Increasing Incidence Rate Of Chronic And Infectious Diseases 29
4.2.2 Increased R&D Investments By Public And Private Organizations 29
4.2.3 Technological Advancements In Immunoassay Testing 30
4.3 Restraints 30
4.3.1 High Cost Of Immunoassay Procedures 30
4.3.2 High Price Of Immunoassay Systems 30
4.4 Opportunity 31
4.4.1 Integration Of The Microfluidics Technology In Immunoassays 31
4.5 Challenge 31
4.5.1 Technical Difficulties During Testing 31
5 Market Factor Analysis
5.1 Value Chain Analysis 33
5.1.1 R&D And Product Development 33
5.1.2 Manufacturing 33
5.1.3 Distribution & Sales 33
5.1.4 Post-Sales Monitoring 34
5.2 Porter’s Five Forces Analysis 34
5.2.1 Bargaining Power Of Suppliers 34
5.2.2 Bargaining Power Of Buyers 35
5.2.3 Threat Of New Entrants 35
5.2.4 Threat Of Substitutes 35
5.2.5 Intensity Of Rivalry 35
5.3 Investment Opportunity Analysis 35
5.4 Pricing Analysis 35
5.5 Major Trends 36
5.5.1 Growing Demand For Automated Immunoassay Systems 36
5.5.2 Development Of Highly Sensitive Immunoassay Equipment 36
5.5.3 Technology Trends 36
5.6 Major Pharmaceutical Organizations (By R&D Revenues) 37
5.7 Top Research Institutes 42
6 Immunoassays In R&D Market, By Product & Service
6.1 Overview 47
6.2 Kits And Reagents 48
6.3 Analyzers 49
6.4 Software And Services 50
7 Immunoassays In R&D Market, By Type
7.1 Overview 52
7.2 Enzyme-Linked Immunosorbent Assay (ELISA) 53
7.3 Enzyme-Linked Immunospot Assay (ELISpot) 54
7.4 RadioImmunoassay (RIA) 55
7.5 Chemiluminescence (CLIA) 56
7.6 Fluoroimmunoassay 57
7.7 Others 57
8 Immunoassays In R&D Market, By Application
8.1 Overview 59
8.2 Infectious Diseases 60
8.3 Cancer Research 61
8.4 Endocrinology 62
8.5 Autoimmune Diseases 63
8.6 Others 63
9 Immunoassays In R&D Market, By End User
9.1 Overview 65
9.2 Pharmaceutical And Biotechnology Companies 66
9.3 Academic Institutions And Laboratories 67
9.4 Others 68
10 Global Immunoassays In R&D Market, By Region
10.1 Overview 70
10.2 Americas 71
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.2.1 North America 74
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.2.1.1 US 77
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.2.1.2 Canada 80
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.2.2 Latin America 82
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3 Europe 85
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1 Western Europe 88
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1.1 Germany 92
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1.2 France 94
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1.3 UK 97
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1.4 Italy 99
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1.5 Spain 102
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1.6 Switzerland 104
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.1.7 Rest Of Western Europe 107
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.2 Nordic Countries 109
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.2.1 Norway 113
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.2.2 Sweden 115
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.2.3 Denmark 118
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.2.4 Rest Of Nordic Countries 120
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.3.3 Eastern Europe 123
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.4 Asia-Pacific 126
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.4.1 Japan 129
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.4.2 China 132
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.4.3 India 134
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.4.4 Australia 137
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.4.5 South Korea 139
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.4.6 Rest Of Asia-Pacific 142
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.5 Middle East & Africa 145
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.5.1 Middle East 148
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
10.5.2 Africa 151
Immunoassays In R&D Market, By Product & Service
Immunoassays In R&D Market, By Type
Immunoassays In R&D Market, By Application
Immunoassays In R&D Market, By End User
11 Company Landscape
11.1 Overview 155
11.2 Company Share Analysis 155
12 Company Profiles
12.1 Bio-Rad Laboratories, Inc. 158
12.1.1 Company Overview 158
12.1.2 Financial Overview 158
12.1.3 Products/Services Offered 159
12.1.4 Key Developments 160
12.1.5 SWOT Analysis 160
12.1.6 Key Strategies 160
12.2 Thermo Fisher Scientific Inc. 161
12.2.1 Company Overview 161
12.2.2 Financial Overview 161
12.2.3 Products/Services Offered 162
12.2.4 Key Developments 163
12.2.5 SWOT Analysis 163
12.2.6 Key Strategies 163
12.3 Siemens Healthineers 164
12.3.1 Company Overview 164
12.3.2 Financial Overview 164
12.3.3 Products/Services Offered 165
12.3.4 Key Developments 165
12.3.5 SWOT Analysis 165
12.3.6 Key Strategies 166
12.4 Becton, Dickinson And Company 167
12.4.1 Company Overview 167
12.4.2 Financial Overview 167
12.4.3 Products/Services Offered 168
12.4.4 Key Developments 168
12.4.5 SWOT Analysis 169
12.4.6 Key Strategies 169
12.5 Danaher Corporation 170
12.5.1 Company Overview 170
12.5.2 Financial Overview 170
12.5.3 Products/Services Offered 171
12.5.4 Key Developments 171
12.5.5 SWOT Analysis 171
12.5.6 Key Strategies 171
12.6 BioMérieux Inc. 172
12.6.1 Company Overview 172
12.6.2 Financial Overview 172
12.6.3 Products/Services Offered 173
12.6.4 Key Developments 173
12.6.5 SWOT Analysis 174
12.6.6 Key Strategies 174
12.7 Abbott Laboratories 175
12.7.1 Company Overview 175
12.7.2 Financial Overview 175
12.7.3 Products/Services Offered 176
12.7.4 Key Developments 176
12.7.5 SWOT Analysis 176
12.7.6 Key Strategies 176
12.8 F. Hoffmann-La Roche Ltd 177
12.8.1 Company Overview 177
12.8.2 Financial Overview 177
12.8.3 Products/Services Offered 178
12.8.4 Key Developments 179
12.8.5 SWOT Analysis 179
12.8.6 Key Strategies 179
12.9 Sysmex Corporation 180
12.9.1 Company Overview 180
12.9.2 Financial Overview 180
12.9.3 Products/Services Offered 181
12.9.4 Key Developments 181
12.9.5 SWOT Analysis 181
12.9.6 Key Strategies 181
12.10 Abcam Plc 182
12.10.1 Company Overview 182
12.10.2 Financial Overview 182
12.10.3 Products/Services Offered 183
12.10.4 Key Developments 183
12.10.5 SWOT Analysis 183
12.10.6 Key Strategies 184
13 Appendix
13.1 Discussion Blue Print 186
14 List Of Tables
TABLE 1 MARKET SYNOPSIS 18
TABLE 2 LIST OF ASSUMPTIONS 20
TABLE 3 TOP COMPANIES (GLOBAL) 37
TABLE 4 TOP AMERICAS COMPANIES 38
TABLE 5 TOP EUROPE COMPANIES 39
TABLE 6 TOP ASIA-PACIFIC COMPANIES 40
TABLE 7 TOP MIDDLE EAST & AFRICA COMPANIES 41
TABLE 8 TOP RESEARCH INSTITUTES IN THE AMERICAS 42
TABLE 9 TOP RESEARCH INSTITUTES IN EUROPE 43
TABLE 10 TOP RESEARCH INSTITUTES IN ASIA-PACIFIC 44
TABLE 11 TOP RESEARCH INSTITUTES IN MIDDLE EAST & AFRICA 45
TABLE 12 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 47
TABLE 13 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR KITS AND REAGENTS, BY REGION, 2020–2027 (USD MILLION) 48
TABLE 14 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 49
TABLE 15 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2020–2027 (USD MILLION) 50
TABLE 16 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 52
TABLE 17 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ELISA, BY REGION, 2020–2027 (USD MILLION) 53
TABLE 18 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ELISPOT, BY REGION, 2020–2027 (USD MILLION) 54
TABLE 19 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR RIA, BY REGION, 2020–2027 (USD MILLION) 55
TABLE 20 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR CLIA, BY REGION, 2020–2027 (USD MILLION) 56
TABLE 21 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR FLUOROIMMUNOASSAY, BY REGION, 2020–2027 (USD MILLION) 57
TABLE 22 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59
TABLE 23 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR INFECTIOUS DISEASES, BY REGION, 2020–2027 (USD MILLION) 60
TABLE 24 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR CANCER RESEARCH, BY REGION, 2020–2027 (USD MILLION) 61
TABLE 25 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ENDOCRINOLOGY, BY REGION, 2020–2027 (USD MILLION) 62
TABLE 26 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2020–2027 (USD MILLION) 63
TABLE 27 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 65
TABLE 28 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION,
2020–2027 (USD MILLION) 66
TABLE 29 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY REGION,
2020–2027 (USD MILLION) 67
TABLE 30 GLOBAL IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 67
TABLE 31 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 70
TABLE 32 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 71
TABLE 33 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 72
TABLE 34 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 35 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73
TABLE 36 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 73
TABLE 37 AMERICAS: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 74
TABLE 38 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
TABLE 39 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 75
TABLE 40 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 75
TABLE 41 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76
TABLE 42 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 76
TABLE 43 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 77
TABLE 44 US: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 77
TABLE 45 US: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 46 US: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 78
TABLE 47 US: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 79
TABLE 48 US: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 79
TABLE 49 CANADA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 80
TABLE 50 CANADA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 51 CANADA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81
TABLE 52 CANADA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 81
TABLE 53 CANADA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 82
TABLE 54 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 82
TABLE 55 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 56 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83
TABLE 57 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 84
TABLE 58 LATIN AMERICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 84
TABLE 59 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 85
TABLE 60 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 86
TABLE 61 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 62 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
TABLE 63 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 87
TABLE 64 EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 88
TABLE 65 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 66 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 89
TABLE 67 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 90
TABLE 68 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90
TABLE 69 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 91
TABLE 70 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 91
TABLE 71 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 92
TABLE 72 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 73 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 74 GERMANY: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 93
TABLE 75 GERMANY: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 94
TABLE 76 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 94
TABLE 77 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 78 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95
TABLE 79 FRANCE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 96
TABLE 80 FRANCE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 96
TABLE 81 UK: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 97
TABLE 82 UK: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 83 UK: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98
TABLE 84 UK: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 98
TABLE 85 UK: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 99
TABLE 86 ITALY: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 99
TABLE 87 ITALY: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 88 ITALY: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100
TABLE 89 ITALY: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 101
TABLE 90 ITALY: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 101
TABLE 91 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 102
TABLE 92 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 93 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 94 SPAIN: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 103
TABLE 95 SPAIN: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 104
TABLE 96 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 104
TABLE 97 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 98 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105
TABLE 99 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 106
TABLE 100 SWITZERLAND: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 106
TABLE 101 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 107
TABLE 102 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 103 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 108
TABLE 104 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 108
TABLE 105 REST OF WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES,
BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 106 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 107 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 110
TABLE 108 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 109 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 111
TABLE 110 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 112
TABLE 111 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 112
TABLE 112 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 113
TABLE 113 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 114 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 114
TABLE 115 NORWAY: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 114
TABLE 116 NORWAY: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 115
TABLE 117 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 115
TABLE 118 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 119 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 120 SWEDEN: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 117
TABLE 121 SWEDEN: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 117
TABLE 122 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 118
TABLE 123 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 124 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
TABLE 125 DENMARK: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 119
TABLE 126 DENMARK: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 127 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 120
TABLE 128 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 129 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 130 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 122
TABLE 131 REST OF NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES,
BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 132 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 123
TABLE 133 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 134 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 135 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 124
TABLE 136 EASTERN EUROPE: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 125
TABLE 137 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 138 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 127
TABLE 139 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 140 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 141 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 128
TABLE 142 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 129
TABLE 143 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 129
TABLE 144 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 145 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
TABLE 146 JAPAN: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 131
TABLE 147 JAPAN: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 131
TABLE 148 CHINA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 132
TABLE 149 CHINA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 150 CHINA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133
TABLE 151 CHINA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 133
TABLE 152 CHINA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 153 INDIA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 154 INDIA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 155 INDIA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 156 INDIA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 136
TABLE 157 INDIA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 136
TABLE 158 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137
TABLE 159 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 160 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138
TABLE 161 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 138
TABLE 162 AUSTRALIA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 139
TABLE 163 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 139
TABLE 164 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 165 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 166 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 141
TABLE 167 SOUTH KOREA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 168 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 142
TABLE 169 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 170 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 171 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 143
TABLE 172 REST OF ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 173 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020–2027 (USD MILLION) 145
TABLE 174 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 146
TABLE 175 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 176 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
TABLE 177 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 147
TABLE 178 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 148
TABLE 179 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 148
TABLE 180 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 181 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 149
TABLE 182 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 150
TABLE 183 MIDDLE EAST: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 150
TABLE 184 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 151
TABLE 185 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 186 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
TABLE 187 AFRICA: IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020–2027 (USD MILLION) 152
TABLE 188 AFRICA: IMMUNOASSAYS IN R&D MARKET FOR ACADEMIC INSTITUTIONS AND LABORATORIES, BY TYPE,
2020–2027 (USD MILLION) 153
15 List Of Figures
FIGURE 1 GLOBAL IMMUNOASSAY IN R&D MARKET: MARKET STRUCTURE 21
FIGURE 2 RESEARCH PROCESS OF MRFR 23
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACHES 26
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE IMMUNOASSAYS IN R&D MARKET 28
FIGURE 5 VALUE CHAIN ANALYSIS: GLOBAL IMMUNOASSAYS IN R&D MARKET 33
FIGURE 6 PORTER’S FIVE FORCE ANALYSIS: GLOBAL IMMUNOASSAYS IN R&D MARKET 34
FIGURE 7 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY PRODUCT & SERVICE, 2020 AND 2027 (USD MILLION) 47
FIGURE 8 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY TYPE, 2020 AND 2027 (USD MILLION) 52
FIGURE 9 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY APPLICATION, 2020 AND 2027 (USD MILLION) 59
FIGURE 10 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY END USER, 2020 AND 2027 (USD MILLION) 65
FIGURE 11 GLOBAL IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 70
FIGURE 12 AMERICAS: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 (%) 71
FIGURE 13 NORTH AMERICA: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 74
FIGURE 14 EUROPE: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 (%) 85
FIGURE 15 WESTERN EUROPE: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 88
FIGURE 16 NORDIC COUNTRIES: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 109
FIGURE 17 ASIA-PACIFIC: IMMUNOASSAYS IN R&D MARKET, BY COUNTRY, 2020 (%) 126
FIGURE 18 MIDDLE EAST & AFRICA: IMMUNOASSAYS IN R&D MARKET, BY REGION, 2020 (%) 145
FIGURE 19 GLOBAL IMMUNOASSAY IN R&D MARKET SHARE ANALYSIS, 2020 (%) 155
